IL15 and cancer: Many studies have investigated the co-expression of one or more cytokines (such as IL-2, IL-7, IL-12, IL-15, IL-18, IL-21, and IL-23), or the combination of their receptors to generate gene-edited interleukin-armored immune cells against cancer.